Minerva Neurosciences Inc. (NERV) |
|
8.93 -0.07 (-0.78%)
|
02-21 16:00 |
|
Open: |
9 |
Pre. Close: |
9 |
|
High:
|
9.14 |
Low:
|
8.83 |
|
Volume:
|
185,932 |
Market Cap:
|
348M |
|
|
|
|
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.149 - 9.199 |
9.199 - 9.241 |
|
Low:
|
8.71 - 8.772 |
8.772 - 8.823 |
|
Close:
|
8.836 - 8.931 |
8.931 - 9.01 |
|
Technical analysis |
as of: 2020-02-21 4:32:21 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 11.17 One year: 13.04 |
| Support: |
Support1: 8.36 Support2: 7.62 |
| Resistance: |
Resistance1: 9.56 Resistance2: 11.17 |
| Pivot: |
8.62  |
| Moving Average: |
MA(5): 8.99 MA(20): 8.50
MA(100): 6.50 MA(250): 6.73 |
| MACD: |
MACD(12,26): 0.32  Signal(9): 0.31 |
| Stochastic oscillator: |
%K(14,3): 71.85 %D(3): 80.09 |
| RSI: |
RSI(14): 59.48 |
| 52-week: |
High: 9.56 Low: 4.01 Change(%): 9.4 |
| Average Vol(K): |
3-Month: 39690 10-Days: 27276 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NERV has closed below upper band by 25.9%. Bollinger Bands are 40% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 19 Dec 2019 18:30:21 +0000
Health Care Sector Update for 12/19/2019: AXSM,PRTK,NERV
Thu, 19 Dec 2019 20:58:37 +0000
Health Care Sector Update for 12/19/2019: NDRA,AXSM,PRTK,NERV
Fri, 20 Dec 2019 01:54:48 +0000
FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed
Thu, 19 Dec 2019 14:20:05 +0000
Health Care Sector Update for 12/19/2019: PRTK, RAD, NERV, JNJ, PFE, ABT, MRK, AMGN
Sat, 05 Oct 2019 17:00:00 +0000
These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
39.03 |
| Shares Float (M) |
37.47 |
|
% Held by Insiders
|
3.87 |
|
% Held by Institutions
|
83.39 |
|
Shares Short (K)
|
3100 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.420 |
|
Book Value (p.s.)
|
1.420 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-27.3 |
|
Return on Equity (ttm)
|
-70.7 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.463 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-39.05 |
|
Levered Free Cash Flow (M)
|
-18.49 |
Stock Valuations |
|
P/E
|
-6.29 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
6.29 |
|
P/S
|
|
|
P/CF
|
-8.93 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
